[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Pure Bioscience (PURE)

Pure Bioscience (PURE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 8,815
  • Shares Outstanding, K 130,018
  • Annual Sales, $ 2,200 K
  • Annual Income, $ -2,400 K
  • EBIT $ -2 M
  • EBITDA $ -2 M
  • 60-Month Beta 0.22
  • Price/Sales 4.37
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on 06/15/26
  • Next Earnings Date 11/04/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Products

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0555 +38.20%
on 07/15/26
0.0799 -4.00%
on 07/21/26
+0.0100 (+14.99%)
since 06/24/26
3-Month
0.0530 +44.72%
on 06/17/26
0.0981 -21.81%
on 05/27/26
+0.0084 (+12.30%)
since 04/24/26
52-Week
0.0386 +98.70%
on 01/20/26
0.1400 -45.21%
on 08/19/25
+0.0058 (+8.18%)
since 07/24/25

Most Recent Stories

More News
PURECORE COMPLETES PHASE ONE EXPLORATION AT CRITICAL MINERALS PROJECT, BANKIER

VANCOUVER, BC, July 22, 2026 /PRNewswire/ -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) ("Purecore" or the "Company")  is pleased to announce geologists from HEG & Associates have completed...

PURE : 0.0767 (+13.13%)
PURECORE COMPLETES PHASE ONE EXPLORATION AT CRITICAL MINERALS PROJECT, BANKIER

VANCOUVER, BC, July 22, 2026 /CNW/ -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) ("Purecore" or the "Company")  is pleased to announce geologists from HEG & Associates have completed the...

PURE : 0.0767 (+13.13%)
Purecore Signs Letter of Intent with Skyharbour to Option the Yurchison Uranium Property in Athabasca Basin

VANCOUVER, BC , July 16, 2026 /CNW/ -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (" Purecore "or the "Company ") is pleased to announce it has entered into a non-binding letter of intent...

PURE : 0.0767 (+13.13%)
SYH.VN : 0.390 (-2.50%)
Purecore Signs Letter of Intent with Skyharbour to Option the Yurchison Uranium Property in Athabasca Basin

VANCOUVER, BC , July 16, 2026 /PRNewswire/ -- Purecore Metals Inc. (CSE: PURE) (FSE: J8Y) (" Purecore "or the "Company ") is pleased to announce it has entered into a non-binding letter...

PURE : 0.0767 (+13.13%)
SYH.VN : 0.390 (-2.50%)
PURE Bioscience Reports Fiscal Third Quarter 2026 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported...

PURE : 0.0767 (+13.13%)
PURE Bioscience Reports Fiscal Second Quarter 2026 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported...

PURE : 0.0767 (+13.13%)
PURE Bioscience Reports Fiscal First Quarter 2026 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported...

PURE : 0.0767 (+13.13%)
PURE Bioscience, Inc. Announces Leadership Promotions

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE” or the “Company”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today announced that...

PURE : 0.0767 (+13.13%)
PURE Bioscience Reports Fiscal 2025 Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported...

PURE : 0.0767 (+13.13%)
PURE Bioscience Reports Fiscal 2023 Second Quarter And Six-Month Financial Results

PURE Bioscience, Inc. ( OTCQB: PURE ), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal second quarter and six-month period...

PURE : 0.0767 (+13.13%)

Business Summary

PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including methicillin-resistant Staphylococcus aureus (MRSA), or staph infection. PURE's proprietary high efficacy/low toxicity bioscience technologies, including its...

See More

Key Turning Points

3rd Resistance Point 0.0898
2nd Resistance Point 0.0832
1st Resistance Point 0.0800
Last Price 0.0767
1st Support Level 0.0702
2nd Support Level 0.0636
3rd Support Level 0.0604

See More

52-Week High 0.1400
Fibonacci 61.8% 0.1013
Fibonacci 50% 0.0893
Fibonacci 38.2% 0.0773
Last Price 0.0767
52-Week Low 0.0386

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.